Suppr超能文献

腹盆腔促结缔组织增生性小圆细胞肿瘤:12例临床病理特征

Desmoplastic small round cell tumor of the abdomen and pelvis: clinicopathological characters of 12 cases.

作者信息

Zhang Guangzhao, Liu Guangjun, Zhao Dahua, Cui Xijun, Li Gang

机构信息

Department of General Surgery, Wuqing District People's Hospital, Tianjin 301700, China.

Department of General Surgery, Wendeng Central Hospital, Shandong, China.

出版信息

ScientificWorldJournal. 2014;2014:549612. doi: 10.1155/2014/549612. Epub 2014 Jun 2.

Abstract

PURPOSE

To study the clinical, radiological, and pathological characteristics of abdominal desmoplastic small round cell tumor (DSRCT) and investigate the optimal therapy modalities.

PATIENTS AND METHODS

A retrospective cohort study was performed on 12 abdominal DSRCT patients; all pathological, radiological, and prognostic data were analyzed. There were 3 patients (25%) with metastatic disease at presentation. In all 12 cases, 6 cases underwent operation and adjuvant chemotherapy (group 1, 6/12, 50%). The other 6 cases were diagnosed by fine needle aspiration or exploratory laparotomy biopsy (group 2, 6/12, 50%); all cases received four to six courses of multiple agents chemotherapy, respectively.

RESULTS

All cases were finally diagnosed as DSRCT pathologically. Among group 1, all cases underwent en bloc resection (2/6, 33%) or tumor debulking (4/6, 67%) and, following four courses of multiple agents chemotherapy, Kaplan-Meier analysis revealed that 3-year survival was 50% in group 1 versus 16.7% in group 2 (P < 0.05). Gross tumor resection was highly significant in prolonging overall survival; patients with localized solitary lesion have a better prognosis, most likely due to increased feasibility of resection.

CONCLUSIONS

DSRCT is a rare malignant tumor with poor prognosis. Surgical excision with combination chemotherapy as an adjunct is mandatory for nonmetastatic cases because these modalities used in isolation may have less impact.

摘要

目的

研究腹部促结缔组织增生性小圆细胞肿瘤(DSRCT)的临床、放射学及病理学特征,并探讨最佳治疗方式。

患者与方法

对12例腹部DSRCT患者进行回顾性队列研究;分析所有病理、放射学及预后数据。3例患者(25%)初诊时即有转移性疾病。12例患者中,6例接受了手术及辅助化疗(第1组,6/12,50%)。另外6例通过细针穿刺或剖腹探查活检确诊(第2组,6/12,50%);所有病例分别接受了四至六个疗程的多药化疗。

结果

所有病例最终经病理确诊为DSRCT。第1组中,所有病例均接受了整块切除(2/6,33%)或肿瘤减瘤手术(4/6,67%),在接受四个疗程的多药化疗后,Kaplan-Meier分析显示第1组3年生存率为50%,而第2组为16.7%(P<0.05)。肿瘤大体切除对延长总生存期具有高度显著意义;局限性孤立性病变患者预后较好,很可能是由于切除的可行性增加。

结论

DSRCT是一种预后较差的罕见恶性肿瘤。对于非转移性病例,必须采用手术切除联合化疗作为辅助治疗,因为单独使用这些方式可能效果较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb0/4060500/3635d80fc8c5/TSWJ2014-549612.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验